Thursday, 22 March 2018

Durex-Maker Reckitt Avoids $20 Billion Headache

Turning down Pfizer’s $20 billion consumer-health business shows discipline, but leaves U.K. giant Reckitt Benckiser with plenty of work.

from WSJ.com: Markets http://ift.tt/2G2ddCm
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)